Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease
{{output}}
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce CKD progression in adults; but pediatric evidence remains limited. We evaluated dapagliflozin in children with non-diabetic CKD. ... ...